Allelic imbalance of 8p indicates poor survival in gastric cancer

Journal of Molecular Diagnostics

Volumn 6, Issue 3, 2004, Pages 243-252

  French, Amy J ^a   Petroni, Gina ^c   Thibideau, Stephen N ^a   Smolkin, Mark ^c   Bissonette, Eric ^c   Roviello, Franco ^b   Harper, Jeffrey C ^c   Koch, Benjamin R ^a   Anderson, Sarah A ^a   Hebbring, Scott J ^a   Powell, Steven M ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CARDIA; CHROMOSOME 8P; CHROMOSOME ARM; CHROMOSOME MARKER; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GEL ELECTROPHORESIS; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STOMACH CANCER; STOMACH SURGERY; TUMOR XENOGRAFT;

EID: 4344664665     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60517-X     Document Type: Article

References (65)

1. Hanai A, Tsujuma H, Hiyama T, Fujimoto I: Gastric Cancer. Edited by T Sugimura, M Sasako. New York, Oxford University Press, 1997, pp 22-30
2. Yokozaki H, Yasui W, Tahara E: Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 2001, 204:49-95
3. Saal K, Vollmers HP, Muller J, Kohler J, Hohn H, Muller-Hermelink HK: Cytogenetic differences between intestinal and diffuse types of human gastric carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1993, 64:145-150
4. Ramesh S, Nash J, McCulloch PG: Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br J Cancer 1999, 81: 1392-1397
5. Muller W, Schneiders A, Hommel G, Gabbert HE: Prognostic value of bcl-2 expression in gastric cancer. Anticancer Res 1998, 18:4699-4704
6. Vollmers HP, Dammrich J, Hensel F, Ribbert H, Meyer-Bahlburg A, Ufken-Gaul T, von Korff M, Muller-Hermelink HK: Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. Cancer 1997, 79:433-440
7. Castedo S, Correia C, David L, Sobrinho-Simoes M: Isochromosome 8q. A recurrent change in gastric carcinoma. Cancer Genet Cytogenet 1991, 54:137-138
8. Virgin JB, Hurley PM, Nahhas FA, Bebchuk KG, Mohamed AN, Sakr WA, Bright RK, Cher ML: Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line. Prostate 1991, 41:49-57
9. Jin Y, Jin C, Wennerberg J, Hoglund M, Mertens F: Cytogenetic and fluorescence in situ hybridization characterization of chromosome 8 rearrangements in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 2001, 130:111-117
10. Mark HF, Afify AM, Werness BA, Das S, Mark S, Samy M: Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization. Exp Mol Pathol 1999, 66:76-81
11. Afify A, Mark HF: Trisomy 8 in embryonal rhabdomyosarcoma detected by fluorescence in situ hybridization. Cancer Genet Cytogenet 1999, 108:127-132
12. Bullerdiek J, Leuschner E, Taquia E, Bonk U, Bartnitzke S: Trisomy 8 as a recurrent clonal abnormality in breast cancer? Cancer Genet Cytogenet 1993, 65:64-67
13. Bofin AM, Ytterhus B, Fjosne HE, Hagmar BM: Abnormal chromosome 8 copy number in cytological smears from breast carcinomas detected by means of fluorescence in situ hybridization (FISH). Cytopathology 2003, 14:5-11
14. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R: Allelotype of colorectal carcinomas. Science 1989, 244:207-211
15. Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y: Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 1993, 53:1172-1174
16. Farrington SM, Cunningham C, Boyle SM, Wyllie AH, Dunlop MG: Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer. Oncogene 1996, 12:1803-1808
17. Fujiwara Y, Ohata H, Emi M, Okui K, Koyama K, Tsuchiya E, Nakajima T, Monden M, Mori T, Kurimasa A: A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chromosom Cancer 1994, 10:7-14
18. Yaremko ML, Wasylyshyn ML, Paulus KL, Michelassi F, Westbrook CA: Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas. Genes Chromosom Cancer 1994, 10: 1-6
19. Cunningham C, Dunlop MG, Bird CC, Wyllie AH: Deletion analysis of chromosome 8p in sporadic colorectal adenomas. Br J Cancer 1994, 70:18-20
20. Cunningham C, Dunlop MG, Wyllie AH, Bird CC: Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene 1993, 8:1391-1396
21. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y: Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 1992, 52:5368-5372
22. Kelemen PR, Yaremko ML, Kim AH, Montag A, Michelassi F, Westbrook CA: Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma. Genes Chromosom Cancer 1994, 11: 195-198
23. Gustafson CE, Wilson PJ, Lukeis R, Baker E, Woollatt E, Annab L, Hawke L, Barrett JC, Chenevix-Trench G: Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer. Cancer Res 1996, 56:5238-5245
24. Halling KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O'Connell MJ, Witzig TE, Farr JR GH, Goldberg RM, Thibodeau SN: Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999, 91:1295-1303
25. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim US: Deletion mapping of chromosome 8p in prostate cancer by fluorescent in situ hybridization. Oncogene 1994, 9:3071-3076
26. Trapman J, Sleddens HFBM, van der Weiden MM, Dinjen NM, Konig JJ, Schroder FH, Faber PW, Bosman FT: Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 1994, 54:6061-6064
27. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietrulk T, Powell J: Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 1995, 55:5390-5395
28. Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y, Shimazaki J: Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2-Mb region of 8p22-p21.3. Genes Chromosom Cancer 1995, 13:168-174
29. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG, Thibodeau SN: Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 1996, 56:4475-4482
30. Knowles MA, Shaw ME, Proctor AJ: Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 1993, 8:1364-1367
31. Ohata H, Emi M, Fujiwara Y, Higashino K, Nakagawa K, Futagami R, Tsuchiya E, Nakamura Y: Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosom Cancer 1993, 7:85-88
32. Pykett MJ, Murphy ME, Harnish PR, Muenke M, Marks J, Goerge DL: Loss of chromosome 8p sequences in human breast carcinoma cell lines. Cancer Genet Cytogenet 1994, 76:23-28
33. Wasylyshyn ML, Neuman WL, Angriman I, Snyder LA, Montag AG, Westbrook CA, Michelassi F: Evidence for a new tumor-suppressor gene involved in gastrointestinal malignancies. Surgery 1991, 110: 265-268
34. Emi M, Fujiwara Y, Ohata H, Tsuda H, Hirohashi S, Koike M, Miyaki M, Monden M, Nakamura Y: Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinomas. Genes Chromosom Cancer 1993, 7:152-157
35. Yustein AS, Harper JC, Petroni GR, Cummings OW, Moskaluk CA, Powell SM: Allelotype of gastric adenocarcinoma. Cancer Res 1999, 59:1437-1441
36. Baffa R, Santoro R, Bullrich F, Mandes B, Ishii H, Croce CM: Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer. Clin Cancer Res 2000, 6:1372-1377
37. Vecchione A, Ishii H, Shiao YH, Trapasso F, Rugge M, Tamburrino JF, Murakumo Y, Alder H, Croce CM, Baffa R: Fez1/Izts1 alterations in gastric carcinoma. Clin Cancer Res 2001, 7:1546-1552
38. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE, Kinzler KW, Vogeistein B: Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996, 13:343-346
39. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-353
40. Goelz S, Hamilton S, Vogelstein B: Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985, 130:118-126
41. Hayden JD, Cawkwell L, Quirke P, Dixon ME, Goldstone AR, Sue-Ling H, Johnston D, Martin IG: Prognostic significance of microsatellite instability in patients with gastric carcinoma. Eur J Cancer 1997, 33:2342-2346
42. Ohmura K, Tamura G, Endoh Y, Sakata K, Takahashi T, Motoyama T: Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype. Hum Pathol 2000, 31:1031-1035
43. Ottini L, Palli D, Falchetti M, D'Amico C, Amorosi A, Saieva C, Calzolari A, Cimoli F, Tatarelli C, De Marchis L, Masala G, Mariani-Costantini R, Cama A: Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 1997, 57:4523-4529
44. Choi S-W, Choi J-R, Chung Y-J, Kim K-M, Rhyu M-G: Prognostic implications of microsatellite genotypes in gastric carcinoma. Int J Cancer 2000, 89:378-383
45. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, McDonnell SK, Schaid DJ, Vockley CW, Michels VV, Fahr Jr GH, O'Connell MJ: Microsatellite instability in colorectal cancer: different mutator phenotypes and the principle involvement of hMLH1. Cancer Res 1998, 58:1713-1718
46. Harrell Jr FE: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, Springer-Verlag, 2001, pp 66-67
47. Muscheck M, Sukosd F, Pesti T, Kovacs G: High density deletion mapping of bladder cancer localizes the putative tumor suppressor gene between loci D8S504 and D8S264 at chromosome 8p23.3. Lab Invest 2000, 80:1089-1093
48. Washburn JG, Wojno KJ, Dey J, Powell J, Macoska JA: 8pter-p23 deletion is associated with racial differences in prostate cancer outcome. Clin Cancer Res 2000, 6:4647-4652
49. Pribill I, Speiser P, Leary J, Leodolter S, Hacker NF, Friedlander ML, Birnbaum D, Zeillinger R, Krainer M: High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma. Cancer Genet Cytogenet 2001, 129:23-29
50. Schneider BG, Bravo JC, Roa JC, Roa I, Kim MC, Lee KM, Plaisance JR KT, McBride CM, Mera R: Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int J Cancer 2000, 89:444-452
51. Wu C-W, Chen G-D, Jiang K-C, Li AF-Y, Chi C-W, Lo S-S, Chen J-Y: A genome-wide study of microsatellite instability in advanced gastric carcinoma. Cancer 2001, 92:92-101
52. Chung YJ, Song JM, Lee JY, Seo EJ, Choi SW, Rhyu MG: Microsatelite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population. Cancer Res 1996, 56:4662-4665
53. dos Santos NR, Seruca R, Constancia M, Seixas M, Sobrinho-Simoes M: Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology 1996, 110:38-44
54. Oliveira C, Seruca R, Seixas M, Sobrinho-Simoes M: The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes." Am J Pathol 1998, 153:1211-1219
55. Seruca R, Santos NR, David L, Constancia M, Barroca H, Carneiro F, Seixas M, Peltomaki P, Lothe R, Sobrinho-Simoes M: Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile. Int J Cancer 1995, 64:32-36
56. Czopek J, Bialas M, Rudzki Z, Zazula M, Pituch-Noworolska A, Zembala M, Popiela T, Kulig J, Kolodziejczyk P, Stachura J: The relationship between gastric cancer cells circulating in the blood and microsatellite instability positive gastric carcinomas. Aliment Pharmacol Ther 2002, 16(Suppl 2):S128-S136
57. Young JL, Ries LG, Pollack ES: Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst 1984, 73:341-352
58. Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-Culver H: Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer 2000, 89:1883-1892
59. La Vecchia C, Franceschi S: Nutrition and gastric cancer. Can J Gastroenterol 2000, 14(Suppl D):51D-54D
60. Palli D: Epidemiology of gastric cancer: an evaluation of available evidence. J Gastroenterology 2000, 35(Suppl 12):84-89
61. Buonsanti G, Calístri D, Padovan L, Luinetti O, Fiocca R, Solcia E, Ranzani GN: Microsatellite instability in intestinal- and diffuse-type gastric carcinoma. J Pathol 1997, 182:167-173
62. Hahn SA, Seymour AB, Hoque AT, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995, 55:4670-4675
63. McQueen H, Wyllie A, Piris J, Foster E, Bird C: Stability of critical genetic lesions in human colorectal carcinoma xenografts. Br J Cancer 1991, 63:94-97
64. Nikiforova MN, Caudill CM, Biddinger P, Nikiforov YE: Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol 2002, 10:15-22
65. Lee KM, Park SK, Kim SU, Doll MA, Yoo KY, Ahn SH, Noh DY, Hirvonen A, Hein DW, Kang D: N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Cancer Lett 2003, 196:179-186